Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis

End‐stage liver fibrosis frequently progresses to portal vein thrombosis, formation of oesophageal varices, hepatic encephalopathy, ascites, hepatocellular carcinoma and liver failure. Mesenchymal stem cells (MSCs), when transplanted in vivo, migrate into fibrogenic livers and then differentiate int...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cellular and molecular medicine Jg. 23; H. 3; S. 1657 - 1670
Hauptverfasser:	Hu, Chenxia, Zhao, Lingfei, Duan, Jinfeng, Li, Lanjuan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley & Sons, Inc 01.03.2019 John Wiley and Sons Inc
Schlagworte:	Animals Ascites Bile Cell Differentiation Cytokines Esophagus Fibrosis Growth factors Hepatic encephalopathy Hepatocellular carcinoma Hepatocytes Humans improvement Inflammation Liver Liver cancer Liver Cirrhosis - pathology Liver Cirrhosis - therapy Liver diseases Liver failure liver fibrosis Liver Regeneration mechanism mesenchymal stem cell Mesenchymal Stem Cell Transplantation - methods Mesenchymal Stem Cells - cytology Mesenchyme Portal vein Quality of life regression Review Reviews Stem cell transplantation Thrombosis mesenchymal stem cell liver fibrosis improvement mechanism regression
ISSN:	1582-1838, 1582-4934, 1582-4934
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!